Dr. Siddhartha Mukherjee
Dr. Siddhartha Mukherjee is a physician, researcher, life science entrepreneur, and Pulitzer Prize-winning author. Dr. Mukherjee has played an essential role in the field of cancer drug development and serves as the CEO for Manas AI.
About Sid
Dr. Sidhartha Mukherjee is an oncologist, immunologist and cancer biologist. An Associate Professor at Columbia University (on leave), and a member of the National Academy of Medicine, Dr. Mukherjee has played an essential role in drug development for cancer. He co-founded Immuneel, a company dedicated to creating novel cellular therapies and reducing the cost of production; Immuneel’s first drug, Qartemi, was approved in India in 2023 (for about one-tenth the price for the comparative drug in the United States). He is the founder of Vor Biopharma, a public company dedicated to finding treatment for blood cancers. Vor presented positive data in a Phase 2 study in 2023, and two of its drugs are entering a Phase 3 trial on FDA’s Fast Track designation. He is also the co-founder of Faeth Therapeutics, which leverages biology and metabolic therapies for cancer and other diseases.
As an author, The Emperor of All Maladies: A Biography of Cancer earned the 2011 Pulitzer Prize for General Nonfiction, and The Gene: An Intimate History won international awards and was recognized by The Washington Post and The New York Times as one of the most influential books of 2016. Both books have been adapted into PBS documentaries by the renowned filmmaker Ken Burns. The Emperor of All Maladies was included among Time magazine’s 100 best nonfiction books of the past century.
Dr. Mukherjee writes for The New Yorker, The New York Times Magazine, and many other publications. He has received numerous awards for his scientific work and has published his original research and opinions in journals such as Nature, Cell, and The New England Journal of Medicine.
A native of India, Dr. Mukherjee received his bachelor’s degree from Stanford University, where he worked in the laboratory of Nobel Laureate Dr. Paul Berg, and his DPhil in immunology from the University of Oxford, where he studied as a Rhodes Scholar. After graduating from Harvard Medical School, he completed his internal medicine residency at the Massachusetts General Hospital and his hematology-oncology fellowship at the Dana-Farber Cancer Institute.